Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer.

The discovery that kidney cells with mutations in a certain gene are sensitive to therapies called PI3K inhibitors opens new opportunities for applying precision medicine to cancer treatment.

W. Kimryn Rathmell, MD, PhD, Cornelius A. Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt University Medical Center (VUMC), has been elected to the nominating committee for the American Society of Clinical Oncology (ASCO).

The 2015 Annual Meeting of the American Society of Clinical Oncology, held May 29 - June 2 in Chicago, put multiple Vanderbilt-Ingram Cancer Center investigators in the spotlight.

On June 1 in Chicago, at the annual meeting of the American Society of Clinical Oncology, a mobile computer application under development at Vanderbilt University Medical Center, called SMART Precision Cancer Medicine (PCM), was featured in a demonstration of improved cancer care coordination through clinical data interoperability and electronic clinical information sharing.

Two leading cancer organizations are calling for regulation of e-cigarettes and other electronic nicotine delivery systems (ENDS).